Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 9,948,910 | 13,985,770 | 10,128,290 | 10,268,060 | 9,360,816 |
| Cost of Goods | 3,143,910 | 4,630,292 | 3,394,741 | 3,471,998 | 3,349,177 |
| Gross Profit | 6,805,000 | 9,355,476 | 6,733,544 | 6,796,057 | 6,011,639 |
| Operating Expenses | 5,745,691 | 6,954,450 | 6,026,836 | 4,339,687 | 6,037,393 |
| Operating Income | 1,060,219 | 2,401,323 | 707,447 | 2,457,368 | -25,576 |
| Interest Expense | 264,034 | 313,721 | 206,157 | 253,985 | 245,530 |
| Other Income | 39,469 | 56,159 | 109,331 | 36,658 | 43,479 |
| Pre-tax Income | 835,654 | 2,143,761 | 610,620 | 2,240,041 | -227,626 |
| Income Tax | 189,179 | 673,920 | 1,046,500 | 413,707 | -117,650 |
| Net Income Continuous | 646,475 | 1,469,842 | -435,880 | 1,826,334 | -109,977 |
| Minority Interests | 46,274 | 406,676 | 241,925 | 239,584 | 120,207 |
| Net Income | $600,201 | $1,063,166 | $-677,805 | $1,586,750 | $-230,184 |
| EPS Basic Total Ops | 0.31 | 0.39 | -0.35 | 0.81 | -0.12 |
| EPS Basic Continuous Ops | 0.33 | 0.75 | -0.22 | 0.93 | -0.06 |
| EPS Diluted Total Ops | 0.30 | 0.39 | -0.35 | 0.80 | -0.12 |
| EPS Diluted Continuous Ops | 0.33 | 0.74 | -0.22 | 0.93 | -0.06 |
| EBITDA(a) | $1,310,987 | $3,066,508 | $439,133 | $3,395,816 | $1,377,552 |